The duration of dual antiplatelet therapy in patients with coronary atherosclerosis after stent implantation
Optimal longevity of dual antiplatelet therapy is uncertain. After implantation of drug-eluting stent 6-12 months dual antiplatelet therapy (DAPT) is needed. After this, some of patients have risk of thrombotic complications, very late stent thrombosis. From other hand, there is real risk of haemorrhagia. This review discuss results of long-term DAPT in clinical trials and meta-analyses on this theme.